Numedico updates

Retractable safety syringe technology results in a used needle retracting safely into the barrel, encapsulating it completely. As such it achieves a number of outcomes preventing needle reuse, encasing the sharp (the needle in its own barrel) and most importantly preventing the spread of blood borne pathogens.

Health care is often a leading issue in political races across the globe, featuring strategies for controlling costs while enhancing the quality of care. A popular component of such plans is greater resourcing of preventive health measures such as cancer screening tests.

New York City-based Icahn School of Medicine at Mount Sinai and Adelaide, South Australia-based Numedico Technologies, have signed a Collaboration Development Agreement (CDA). The international collaboration team will design, develop and commercialise a device for the screening and early detection of endometrial and ovarian cancers.

Every 60 minutes, of every day, six people suffer a needlestick injury somewhere in the world. Every day, 3 people die as a result of those injuries[1]. The World Health Organisation (WHO) reports in the World Health Report 2002, that of the 35 million health-care workers world wide, two million experience percutaneous exposure to infectious diseases each year[2].

Recently Neville Calvert MD was interviewed by The Silicon Review, the world’s most trusted online and print community for business & technology professionals. To be featured in the February issue of the global magazine, and recognised as one of the 30 Fabulous Companies of the year, Calvert talks about the Numedico journey, mission and ethos as well as what he sees as the way forward in safe medical device technology.

It is with pleasure that we can announce that Numedico Technologies has been nominated as a winner in the 2020 Global Med-Tech Awards. Announced this week, Global Health and Pharma Magazine published the results of the 3rd annual MedTech Awards. This year the GHP News Medtech Awards 2020, celebrated those who have demonstrated an ability to innovate in this industry. 

Challenging the status quo and innovating through safety and transparency, Numedico Technologies continues to drive innovation in the medical devices space. It has yet again been awarded as a positive disruptor in the industry by the global magazine CEO VIEWS.

Numedico Technologies Pty Ltd (Numedico) and Omikron Group Ltd (OGL) are pleased to announce the completion and settlement of the acquisition of the global ClickZip assets and Omikron business

Numedico Science Pty Ltd, a subsidiary of Numedico Technologies Pty Ltd, has committed to a collaborative partnership with space medtech start-up ResearchSat to explore and expand the development of novel drug delivery methods and therapeutics.

Numedico has signed a global distribution partnership with UAE-based leading medical devices distributor PBC Medicals L.L.C The partnership, worth US$5.5 million dollars over the next two years, will see Numedico distribute their ClickZip™ Safety Syringe technology into these global markets.